244 related articles for article (PubMed ID: 17141979)
41. Weekly response assessment of involved lymph nodes to radiotherapy using diffusion-weighted MRI in oropharynx squamous cell carcinoma.
Tyagi N; Riaz N; Hunt M; Wengler K; Hatzoglou V; Young R; Mechalakos J; Lee N
Med Phys; 2016 Jan; 43(1):137. PubMed ID: 26745906
[TBL] [Abstract][Full Text] [Related]
42. Lymph node metastasis in head and neck squamous carcinoma: Efficacy of intravoxel incoherent motion magnetic resonance imaging for the differential diagnosis.
Liang L; Luo X; Lian Z; Chen W; Zhang B; Dong Y; Liang C; Zhang S
Eur J Radiol; 2017 May; 90():159-165. PubMed ID: 28583628
[TBL] [Abstract][Full Text] [Related]
43. PET measured hypoxia and MRI parameters in re-irradiated head and neck squamous cell carcinomas: findings of a prospective pilot study.
Rogasch J; Beck M; Stromberger C; Hofheinz F; Ghadjar P; Wust P; Budach V; Amthauer H; Tinhofer I; Furth C; Walter-Rittel TC; Zschaeck S
F1000Res; 2020; 9():1350. PubMed ID: 33796277
[No Abstract] [Full Text] [Related]
44. Diffusion-weighted imaging for head and neck squamous cell carcinoma: quantifying repeatability to understand early treatment-induced change.
Hoang JK; Choudhury KR; Chang J; Craciunescu OI; Yoo DS; Brizel DM
AJR Am J Roentgenol; 2014 Nov; 203(5):1104-8. PubMed ID: 25341151
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of the larynx for tumour recurrence by diffusion-weighted MRI after radiotherapy: initial experience in four cases.
Vandecaveye V; de Keyzer F; Vander Poorten V; Deraedt K; Alaerts H; Landuyt W; Nuyts S; Hermans R
Br J Radiol; 2006 Aug; 79(944):681-7. PubMed ID: 16641411
[TBL] [Abstract][Full Text] [Related]
46. Pretreatment apparent diffusion coefficient of the primary lesion correlates with local failure in head-and-neck cancer treated with chemoradiotherapy or radiotherapy.
Hatakenaka M; Nakamura K; Yabuuchi H; Shioyama Y; Matsuo Y; Ohnishi K; Sunami S; Kamitani T; Setoguchi T; Yoshiura T; Nakashima T; Nishikawa K; Honda H
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):339-45. PubMed ID: 20832179
[TBL] [Abstract][Full Text] [Related]
47. Correlation of human papillomavirus status with apparent diffusion coefficient of diffusion-weighted MRI in head and neck squamous cell carcinomas.
Driessen JP; van Bemmel AJ; van Kempen PM; Janssen LM; Terhaard CH; Pameijer FA; Willems SM; Stegeman I; Grolman W; Philippens ME
Head Neck; 2016 Apr; 38 Suppl 1():E613-8. PubMed ID: 25783872
[TBL] [Abstract][Full Text] [Related]
48. Role of diffusion-weighted MRI in differentiation of masticator space malignancy from infection.
Abdel Razek AA; Nada N
Dentomaxillofac Radiol; 2013; 42(4):20120183. PubMed ID: 23420858
[TBL] [Abstract][Full Text] [Related]
49. Detection of residual head and neck squamous cell carcinoma after (chemo)radiotherapy: a pilot study assessing the value of diffusion-weighted magnetic resonance imaging as an adjunct to PET-CT using
Noij DP; Jagesar VA; de Graaf P; de Jong MC; Hoekstra OS; de Bree R; Castelijns JA
Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Sep; 124(3):296-305.e2. PubMed ID: 28539202
[TBL] [Abstract][Full Text] [Related]
50. Utility of pretreatment mean apparent diffusion coefficient and apparent diffusion coefficient histograms in prediction of outcome to chemoradiation in head and neck squamous cell carcinoma.
Srinivasan A; Chenevert TL; Dwamena BA; Eisbruch A; Watcharotone K; Myles JD; Mukherji SK
J Comput Assist Tomogr; 2012; 36(1):131-7. PubMed ID: 22261783
[TBL] [Abstract][Full Text] [Related]
51. Head and neck squamous cell carcinoma: diagnostic performance of diffusion-weighted MR imaging for the prediction of treatment response.
King AD; Chow KK; Yu KH; Mo FK; Yeung DK; Yuan J; Bhatia KS; Vlantis AC; Ahuja AT
Radiology; 2013 Feb; 266(2):531-8. PubMed ID: 23151830
[TBL] [Abstract][Full Text] [Related]
52. Apparent diffusion coefficient for discriminating metastatic lymph nodes in patients with squamous cell carcinoma of the head and neck.
Pekçevik Y; Çukurova İ; Arslan İB
Diagn Interv Radiol; 2015; 21(5):397-402. PubMed ID: 26200481
[TBL] [Abstract][Full Text] [Related]
53. Initial experience of 3-tesla apparent diffusion coefficient values in characterizing squamous cell carcinomas of the head and neck.
Srinivasan A; Dvorak R; Rohrer S; Mukherji SK
Acta Radiol; 2008 Nov; 49(9):1079-84. PubMed ID: 18785024
[TBL] [Abstract][Full Text] [Related]
54. Screening for distant metastases before salvage surgery in patients with recurrent head and neck squamous cell carcinoma: a retrospective case series comparing thoraco-abdominal CT, positron emission tomography and abdominal ultrasound.
Fakhry N; Michel J; Colavolpe C; Varoquaux A; Dessi P; Giovanni A
Clin Otolaryngol; 2012 Jun; 37(3):197-206. PubMed ID: 22520870
[TBL] [Abstract][Full Text] [Related]
55. Head and neck squamous cell carcinoma: differentiation of histologic grade with standard- and high-b-value diffusion-weighted MRI.
Yun TJ; Kim JH; Kim KH; Sohn CH; Park SW
Head Neck; 2013 May; 35(5):626-31. PubMed ID: 22605653
[TBL] [Abstract][Full Text] [Related]
56. MRI with DWI for the Detection of Posttreatment Head and Neck Squamous Cell Carcinoma: Why Morphologic MRI Criteria Matter.
Ailianou A; Mundada P; De Perrot T; Pusztaszieri M; Poletti PA; Becker M
AJNR Am J Neuroradiol; 2018 Apr; 39(4):748-755. PubMed ID: 29449279
[TBL] [Abstract][Full Text] [Related]
57. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.
Kitagawa Y; Nishizawa S; Sano K; Ogasawara T; Nakamura M; Sadato N; Yoshida M; Yonekura Y
J Nucl Med; 2003 Feb; 44(2):198-206. PubMed ID: 12571209
[TBL] [Abstract][Full Text] [Related]
58. Diffusion-weighted MRI in head and neck cancer.
Hermans R; Vandecaveye V
JBR-BTR; 2007; 90(4):264-7. PubMed ID: 17966242
[TBL] [Abstract][Full Text] [Related]
59. Comparison of ferucarbotran-enhanced fluid-attenuated inversion-recovery echo-planar, T2-weighted turbo spin-echo, T2*-weighted gradient-echo, and diffusion-weighted echo-planar imaging for detection of malignant liver lesions.
Fukukura Y; Kamiyama T; Takumi K; Shindo T; Higashi R; Nakajo M
J Magn Reson Imaging; 2010 Mar; 31(3):607-16. PubMed ID: 20187203
[TBL] [Abstract][Full Text] [Related]
60. Time-dependent diffusion MRI to distinguish malignant from benign head and neck tumors.
Iima M; Yamamoto A; Kataoka M; Yamada Y; Omori K; Feiweier T; Togashi K
J Magn Reson Imaging; 2019 Jul; 50(1):88-95. PubMed ID: 30578563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
